<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01828268</url>
  </required_header>
  <id_info>
    <org_study_id>META-HA-001-2013</org_study_id>
    <nct_id>NCT01828268</nct_id>
  </id_info>
  <brief_title>Metabolomics Fingerprinting and Metabolic Dynamics After HIV Infection</brief_title>
  <official_title>Metabolic Fingerprintings and Metabolic Dynamics After HIV Infection:Impact of Metabolic Changes and Anti-Retroviral Therapy, Life Style and Clinical Conditions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sichuan Academy of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sichuan Academy of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this plot study is to find out the relationship between metabolic changes and
      anti-retroviral therapy (ART), life style and clinical conditions of HIV-infected patients
      using nuclear magnetic resonance (NMR) based systems biology approach and metabolomics
      methodology.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Since the clinical application of anti-retroviral therapy (ART) in 1997, the life expectancy
      of HIV infected patients has been prolonged greatly. However,side effects of ART including
      metabolic abnormalities have become the main factors influencing patients' quality of life.
      Among which the abnormal lipid metabolism plays an important role. Meanwhile, metabolic
      conditions differ from patients applying to different combinations of ART drugs,life style
      and clinical conditions.

      Metabolomics can measure the dynamic metabolic responses of the body to stimuli or
      modifications. Using nuclear magnetic resonance (NMR) as tools can systematically analyse the
      process of lipid metabolism. Metabolomics fingerprinting can be defined as the complete
      complement of small molecule (&lt; 1500 Da) metabolites found in a specific cell, body fluid,
      organ or organism.

      Therefore, the study of the impact of metabolic changes and anti-retroviral therapy (ART),
      life style and clinical conditions is of importance in enhancing the adherence and improving
      the clinical outcomes of HIV infected patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Dyslipidemia</measure>
    <time_frame>Dyslipidemia events from admission to discharge(Up to 6 months) )</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lipoatrophy</measure>
    <time_frame>Lipoarophy events from admission to discharge (up to 6 months)</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>HIV</condition>
  <arm_group>
    <arm_group_label>HIV infectors</arm_group_label>
    <description>100 confirmed HIV-1 infected patients who meet inclusion criteria.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma from peripheral blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Recruit 100 HIV-infected individuals from community HIV Clinic and/or Transmitted Disease
        Hospital of Chengdu
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of HIV infection

        Exclusion Criteria:

          -  Pregnancy

          -  Individual who is participating in other trial(s)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hua JIANG, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>3Sichuan Academy of Medical Science, Sichuan Provincial People's Hospital, East Branch, Metabonomics and Multidisciplinary Laboratory</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jin PENG, Master</last_name>
    <role>Principal Investigator</role>
    <affiliation>3Sichuan Academy of Medical Science, Sichuan Provincial People's Hospital, East Branch, Metabonomics and Multidisciplinary Laboratory</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hua JIANG, PhD</last_name>
    <phone>+86-28-88424391</phone>
    <email>hua.jiang@traumabank.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bing CAI, Master</last_name>
    <phone>+86-28-88424391</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sichuan Academy of Medical Sciences,Sichuan Provincial Hospital, Metabolomics and Mutidisciplinary Laboratory</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610101</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hua JIANG, PhD</last_name>
      <phone>+86-28-88424391</phone>
      <email>hua.jiang@truamabank.org</email>
    </contact>
    <investigator>
      <last_name>Jin PENG, Master</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Schackman BR, Scott CA, Sax PE, Losina E, Wilkin TJ, McKinnon JE, Swindells S, Weinstein MC, Freedberg KA. Potential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial. Clin Infect Dis. 2007 Oct 15;45(8):1062-70. Epub 2007 Sep 4.</citation>
    <PMID>17879926</PMID>
  </reference>
  <reference>
    <citation>Joly V, Flandre P, Meiffredy V, Leturque N, Harel M, Aboulker JP, Yeni P. Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trial. AIDS. 2002 Dec 6;16(18):2447-54.</citation>
    <PMID>12461419</PMID>
  </reference>
  <reference>
    <citation>John M, McKinnon EJ, James IR, Nolan DA, Herrmann SE, Moore CB, White AJ, Mallal SA. Randomized, controlled, 48-week study of switching stavudine and/or protease inhibitors to combivir/abacavir to prevent or reverse lipoatrophy in HIV-infected patients. J Acquir Immune Defic Syndr. 2003 May 1;33(1):29-33.</citation>
    <PMID>12792352</PMID>
  </reference>
  <reference>
    <citation>Zhang F, Dou Z, Ma Y, Zhao Y, Liu Z, Bulterys M, Chen RY. Five-year outcomes of the China National Free Antiretroviral Treatment Program. Ann Intern Med. 2009 Aug 18;151(4):241-51, W-52.</citation>
    <PMID>19687491</PMID>
  </reference>
  <reference>
    <citation>Zyromski NJ, Mathur A, Gowda GA, Murphy C, Swartz-Basile DA, Wade TE, Pitt HA, Raftery D. Nuclear magnetic resonance spectroscopy-based metabolomics of the fatty pancreas: implicating fat in pancreatic pathology. Pancreatology. 2009;9(4):410-9. doi: 10.1159/000199436. Epub 2009 May 19.</citation>
    <PMID>19451751</PMID>
  </reference>
  <results_reference>
    <citation>Friis-Møller N, Weber R, Reiss P, Thiébaut R, Kirk O, d'Arminio Monforte A, Pradier C, Morfeldt L, Mateu S, Law M, El-Sadr W, De Wit S, Sabin CA, Phillips AN, Lundgren JD; DAD study group. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study. AIDS. 2003 May 23;17(8):1179-93.</citation>
    <PMID>12819520</PMID>
  </results_reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 5, 2013</study_first_submitted>
  <study_first_submitted_qc>April 9, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 10, 2013</study_first_posted>
  <last_update_submitted>April 26, 2017</last_update_submitted>
  <last_update_submitted_qc>April 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>Metabolomics Fingerprinting</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
    <mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

